BACKGROUND: Mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) approaches 70 - 80%, regardless of the type of pharmacological treatment. Early revascularisation improves survival in AMI with CS. Our aim is to assess the predictors of mid-term outcome after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and CS. METHODS: Forty-one patients who underwent primary or rescue PCI for CS were analysed comparing their baseline, angiographic, PCI data, 30-day and 1-year survival. RESULTS: There were no significant differences between survivors and non-survivors in baseline characters, except for more number of transfer admissions (P= 0.0005), and cardiopulmonary resuscitations (P= 0.015) in the later group. The mean time between myocardial infarction (MI) onset to shock and MI onset to revascularisation were 12.8 ± 12.9 hours and 17.0 ± 16.8 hours, respectively. Patients with better pre-procedure thrombolysis in myocardial infarction (TIMI) flow in the infarct-related artery (IRA) had better survival (P= 0.0005). Successful PCI was achieved in 48.8% of patients. The 30-day mortality was 56.1% and all were prior to hospital discharge. Patients with successful PCI had better short-term survival in comparison with patients with failed PCI (80% vs 9.6%). Eighteen patients who survived at 30 days were followed up for 12-72 months (mean 28.5 ± 5.4 months). Fifteen patients survived at 1 year after PCI and all were in good functional status. CONCLUSION: Mortality remains high even with PCI. Achieving IRA patency with TIMI 3 flow is the main determinant of survival. Survival and functional status are good in patients who are discharged from hospital.
BACKGROUND: Mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) approaches 70 - 80%, regardless of the type of pharmacological treatment. Early revascularisation improves survival in AMI with CS. Our aim is to assess the predictors of mid-term outcome after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and CS. METHODS: Forty-one patients who underwent primary or rescue PCI for CS were analysed comparing their baseline, angiographic, PCI data, 30-day and 1-year survival. RESULTS: There were no significant differences between survivors and non-survivors in baseline characters, except for more number of transfer admissions (P= 0.0005), and cardiopulmonary resuscitations (P= 0.015) in the later group. The mean time between myocardial infarction (MI) onset to shock and MI onset to revascularisation were 12.8 ± 12.9 hours and 17.0 ± 16.8 hours, respectively. Patients with better pre-procedure thrombolysis in myocardial infarction (TIMI) flow in the infarct-related artery (IRA) had better survival (P= 0.0005). Successful PCI was achieved in 48.8% of patients. The 30-day mortality was 56.1% and all were prior to hospital discharge. Patients with successful PCI had better short-term survival in comparison with patients with failed PCI (80% vs 9.6%). Eighteen patients who survived at 30 days were followed up for 12-72 months (mean 28.5 ± 5.4 months). Fifteen patients survived at 1 year after PCI and all were in good functional status. CONCLUSION: Mortality remains high even with PCI. Achieving IRA patency with TIMI 3 flow is the main determinant of survival. Survival and functional status are good in patients who are discharged from hospital.
Authors: F Fabbiocchi; A L Bartorelli; P Montorsi; S Cozzi; D Trabattoni; G Calligaris; A Loaldi Journal: Catheter Cardiovasc Interv Date: 2000-08 Impact factor: 2.692
Authors: P Urban; J C Stauffer; D Bleed; N Khatchatrian; W Amann; O Bertel; M van den Brand; N Danchin; U Kaufmann; B Meier; J Machecourt; M Pfisterer Journal: Eur Heart J Date: 1999-07 Impact factor: 29.983
Authors: J G Webb; T A Sanborn; L A Sleeper; R G Carere; C E Buller; J N Slater; K W Baran; P T Koller; J D Talley; M Porway; J S Hochman Journal: Am Heart J Date: 2001-06 Impact factor: 4.749
Authors: Albert W Chan; Derek P Chew; Deepak L Bhatt; David J Moliterno; Eric J Topol; Stephen G Ellis Journal: Am J Cardiol Date: 2002-01-15 Impact factor: 2.778
Authors: T A Sanborn; L A Sleeper; E R Bates; A K Jacobs; J Boland; J K French; J Dens; V Dzavik; S T Palmeri; J G Webb; M Goldberger; J S Hochman Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: J G Webb; L A Sleeper; C E Buller; J Boland; A Palazzo; E Buller; H D White; J S Hochman Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Babu Kunadian; Kunadian Vijayalakshmi; Joel Dunning; Andrew R Thornley; Andrew G C Sutton; Douglas F Muir; Robert A Wright; James A Hall; Mark A de Belder Journal: J Invasive Cardiol Date: 2007-05 Impact factor: 2.022
Authors: Mandeep Singh; Jennifer White; David Hasdai; Patricia K Hodgson; Peter B Berger; Eric J Topol; Robert M Califf; David R Holmes Journal: J Am Coll Cardiol Date: 2007-10-30 Impact factor: 24.094
Authors: Mohammad S Islam; Prashanth Panduranga; Mohammed Al-Mukhaini; Abdullah Al-Riyami; Mohammad El-Deeb; Said Abdul Rahman; Mohammed B Al-Riyami Journal: Oman Med J Date: 2016-01
Authors: Andriany Qanitha; Nurul Qalby; Muzakkir Amir; Cuno S P M Uiterwaal; Jose P S Henriques; Bastianus A J M de Mol; Idar Mappangara Journal: Glob Heart Date: 2022-09-13